Waldera-Lupa, Daniel M., Poschmann, Gereon, Kirchgaessler, Nina, Etemad-Parishanzadeh, Omid, Baberg, Falk, Brocksieper, Mareike, Seidel, Sabine, Kowalski, Thomas, Brunn, Anna, Haghikia, Aiden, Gold, Ralf, Stefanski, Anja, Deckert, Martina, Schlegel, Uwe and Stuhler, Kai (2020). A Multiplex Assay for the Stratification of Patients with Primary Central Nervous System Lymphoma Using Targeted Mass Spectrometry. Cancers, 12 (7). BASEL: MDPI. ISSN 2072-6694

Full text not available from this repository.

Abstract

Primary central nervous system lymphomas (PCNSL) account for approximately 2% to 3% of all primary brain tumors. Until now, neuropathological tumor tissue analysis, most frequently gained by stereotactic biopsy, is still the diagnostic gold standard. Here, we rigorously analyzed two independent patient cohorts comprising the clinical entities PCNSL (n= 47), secondary central nervous system lymphomas (SCNSL;n= 13), multiple sclerosis (MS,n= 23), glioma (n= 10), other tumors (n= 17) and tumor-free controls (n= 21) by proteomic approaches. In total, we identified more than 1220 proteins in the cerebrospinal fluid (CSF) and validated eight candidate biomarkers by a peptide-centric approach in an independent patient cohort (n= 63). Thus, we obtained excellent diagnostic accuracy for the stratification between PCNSL, MS and glioma patients as well as tumor-free controls for three peptides originating from the three proteins VSIG4, GPNMB4 and APOC2. The combination of all three biomarker candidates resulted in diagnostic accuracy with an area under the curve (AUC) of 0.901 (PCNSL vs. MS), AUC of 0.953 (PCNSL vs. glioma) and AUC 0.850 (PCNSL vs. tumor-free control). In summary, the determination of VSIG4, GPNMB4 and APOC2 in CSF as novel biomarkers for supporting the diagnosis of PCNSL is suggested.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Waldera-Lupa, Daniel M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Poschmann, GereonUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kirchgaessler, NinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Etemad-Parishanzadeh, OmidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baberg, FalkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brocksieper, MareikeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Seidel, SabineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kowalski, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brunn, AnnaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Haghikia, AidenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gold, RalfUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stefanski, AnjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Deckert, MartinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schlegel, UweUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Stuhler, KaiUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-327468
DOI: 10.3390/cancers12071732
Journal or Publication Title: Cancers
Volume: 12
Number: 7
Date: 2020
Publisher: MDPI
Place of Publication: BASEL
ISSN: 2072-6694
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
CSF SOLUBLE CD27; CEREBROSPINAL-FLUID; PROTEIN; DIAGNOSIS; INTERLEUKIN-10; BIOMARKER; FEATURESMultiple languages
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/32746

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item